Ulcerative Colitis clinical trials at UC Davis

1 research study open to eligible people

Showing trials for

  • Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community”

    open to eligible people ages 18-75

    The goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderate to severe ulcerative colitis. The study will compare participants in different treatment groups treated with tilpisertib fosmecarbil with participants treated with placebo. The primary objective of this study is to demonstrate the efficacy of tilpisertib fosmecarbil, compared to placebo control, in achieving Clinical Response at Week 12.

    Sacramento, California and other locations

Last updated: